Get an alert when SIGMA-ALDRICH COMPANY LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-12 (in 6mo)

Last made up 2025-10-29

Watchouts

None on the register

Cash

£3M

Latest balance sheet

Net assets

£716M

+0.1% vs 2023

Employees

444

+1.8% vs 2023

Profit before tax

£80M

+142.9% vs 2023

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £246,838,000£253,790,000
Operating profit £27,961,000£35,008,000
Profit before tax £33,039,000£80,257,000
Net profit £25,952,000£70,618,000
Cash £2,803,000
Total assets less current liabilities £715,468,000£717,258,000
Net assets £715,468,000£716,255,000
Equity £715,468,000£716,255,000
Average employees 436444
Wages £18,760,000£19,801,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 11.3%13.8%
Net margin 10.5%27.8%
Return on capital employed 3.9%4.9%
Current ratio 10.66x10.23x
Interest cover 614.18x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Deloitte LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The Directors have prepared cash flow forecasts covering at least 12 months from the date of signing these financial statements. The company will have sufficient funds through its central cash pooling account to meet its liabilities as they fall due for that period. In preparing these forecasts, they have taken a prudent approach, in which the average margin for the past three years has been used, where this is lower than the margin achieved for the last 12 months. They also noted that the company has a positive net assets and positive net current assets position as at the balance sheet date. Consequently, the directors are confident that the Company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”

Group structure

  1. SIGMA-ALDRICH COMPANY LIMITED · parent
    1. SAFC Biosciences Limited 100% · United Kingdom · Distributor of Life Science products
    2. Epichem Group Limited 100% · United Kingdom · Holding company
    3. Millipore (U.K.) Limited 100% · United Kingdom · Manufacturer of monoclonal antibodies
    4. Sigma Chemical Company Limited 100% · United Kingdom · Holding company

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 21 resigned

Name Role Appointed Born Nationality
A G SECRETARIAL LIMITED Corporate Secretary 2016-05-01
CAMARGO, Mauricio Monte Ferraz De Director 2024-12-20 Nov 1982 Brazilian
MASSEY, Alison Eve Director 2023-03-01 Sep 1964 British
Show 21 resigned officers
Name Role Appointed Resigned
CREIGHTON, Anthony John Secretary 1993-12-21
LUCAS, Graham Secretary 2001-04-02 2015-08-27
MUSSELWHITE, Roger Secretary 1993-12-21 2001-03-31
BIRO, Peter Director 2017-07-01 2023-03-01
CREIGHTON, Anthony John Director 2001-03-31
GLEICH, Peter Anthony Director 1998-03-31
GORDON, Leigh Cameron Director 2024-08-02 2024-12-20
GREEN, Eric Mark Director 2001-04-02 2014-03-18
HARRIS, Michael Christopher James Director 2007-08-13 2011-12-19
HEFFERNAN, James Gerard, Dr Director 2000-11-01 2002-07-31
HOLLENKAMP, Michael James Director 2014-03-18 2015-11-24
HUMPHRYES, Kenneth Charles Director 1993-12-21 2000-07-25
JACKSON, Victor Mark Director 2015-08-27 2024-08-02
KRATZER, Stefan Director 2016-05-26 2017-07-01
LUCAS, Graham Director 2002-07-31 2015-08-27
OLDFIELD, Fiona Director 2014-03-18 2016-03-31
SCHRAISHUHN, Lutz Director 2014-03-18 2016-11-14
SMITH, David Robert Clement Director 2000-11-01 2002-07-31
SMITH, Robert William Director 2002-09-16
VAN DEN DOOL, Gerrit Johannis Cornelis Director 2000-11-01 2016-11-11
VAN OUDENAREN, Henry Director 2005-01-04 2007-08-13

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Merck Kgaa Corporate entity Shares 75–100%, Voting 75–100% 2016-04-06 Active

Filing timeline

Last 20 of 142 total filings

Date Type Category Description
2025-10-29 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-11 AA accounts Accounts with accounts type full
2025-01-27 AP01 officers Appoint person director company with name date PDF
2025-01-27 TM01 officers Termination director company with name termination date PDF
2024-11-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-10-02 AA accounts Accounts with accounts type full
2024-09-09 AP01 officers Appoint person director company with name date PDF
2024-09-06 TM01 officers Termination director company with name termination date PDF
2023-11-07 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-25 AA accounts Accounts with accounts type full
2023-03-01 AP01 officers Appoint person director company with name date PDF
2023-03-01 TM01 officers Termination director company with name termination date PDF
2023-01-03 AA accounts Accounts with accounts type full
2022-10-31 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-11-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-06-30 AA accounts Accounts with accounts type full
2020-12-07 AA accounts Accounts with accounts type full
2020-11-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-06-29 CH01 officers Change person director company with change date PDF
2019-11-05 CS01 confirmation-statement Confirmation statement with updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page